- Home
- AQMS vs ADTX Comparison
AQMS vs ADTX Comparison
Compare AQMS & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- ADTX
- Stock Information
- Founded
- AQMS 2014
- ADTX 2017
- Country
- AQMS United States
- ADTX United States
- Employees
- AQMS N/A
- ADTX N/A
- Industry
- AQMS Metal Fabrications
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- AQMS Industrials
- ADTX Health Care
- Exchange
- AQMS Nasdaq
- ADTX Nasdaq
- Market Cap
- AQMS 5.1M
- ADTX 5.1M
- IPO Year
- AQMS 2015
- ADTX 2020
- Fundamental
- Price
- AQMS $3.75
- ADTX $0.91
- Analyst Decision
- AQMS Buy
- ADTX
- Analyst Count
- AQMS 1
- ADTX 0
- Target Price
- AQMS $30.00
- ADTX N/A
- AVG Volume (30 Days)
- AQMS 35.1K
- ADTX 222.0K
- Earning Date
- AQMS 08-13-2025
- ADTX 08-14-2025
- Dividend Yield
- AQMS N/A
- ADTX N/A
- EPS Growth
- AQMS N/A
- ADTX N/A
- EPS
- AQMS N/A
- ADTX N/A
- Revenue
- AQMS N/A
- ADTX $12,051.00
- Revenue This Year
- AQMS N/A
- ADTX $15,768.94
- Revenue Next Year
- AQMS $550.00
- ADTX N/A
- P/E Ratio
- AQMS N/A
- ADTX N/A
- Revenue Growth
- AQMS N/A
- ADTX N/A
- 52 Week Low
- AQMS $3.37
- ADTX $0.81
- 52 Week High
- AQMS $46.00
- ADTX $5,300.00
- Technical
- Relative Strength Index (RSI)
- AQMS 44.14
- ADTX 32.99
- Support Level
- AQMS $3.55
- ADTX $0.90
- Resistance Level
- AQMS $4.35
- ADTX $1.13
- Average True Range (ATR)
- AQMS 0.31
- ADTX 0.07
- MACD
- AQMS 0.10
- ADTX -0.01
- Stochastic Oscillator
- AQMS 38.78
- ADTX 2.57
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.